Nexalin Competitors
| NXL Stock | USD 2.15 0.20 10.26% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Nexalin Technology competition on your existing holdings.
Nexalin |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nexalin Technology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nexalin Technology Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Nexalin Technology and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Nexalin and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Nexalin Technology does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Nexalin Stock performing well and Nexalin Technology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nexalin Technology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AIMDW | 25.58 | 7.29 | 0.27 | (4.34) | 18.27 | 72.73 | 232.19 | |||
| ELMD | 2.43 | 0.01 | 0.00 | (0.13) | 0.00 | 4.11 | 21.31 | |||
| ARMM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SRDX | 1.43 | (0.43) | 0.00 | (0.96) | 0.00 | 1.73 | 10.84 | |||
| BJDX | 6.24 | (0.06) | 0.00 | (0.18) | 0.00 | 12.20 | 42.86 | |||
| INVO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MOTS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| IRIX | 2.77 | (0.62) | 0.00 | (0.68) | 0.00 | 5.13 | 18.82 | |||
| AZYO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AIMD | 5.86 | 0.50 | 0.10 | (1.01) | 6.08 | 17.74 | 74.23 |
Cross Equities Net Income Analysis
Compare Nexalin Technology and related stocks such as Ainos Inc, Electromed, and Armm Inc Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIMDW | (300 K) | (1.3 M) | (650.8 K) | (622.6 K) | (622.6 K) | (521.9 K) | (670 K) | (617.4 K) | (1.3 M) | (1.6 M) | (1.5 M) | (3.9 M) | (14 M) | (13.8 M) | (14.9 M) | (14.1 M) |
| ELMD | 267.9 K | 186.6 K | (1.3 M) | (1.3 M) | 1.1 M | 2.2 M | 2.2 M | 1.9 M | 2 M | 4.2 M | 2.4 M | 2.3 M | 3.2 M | 5.2 M | 5.9 M | 6.2 M |
| SRDX | 1.6 M | 10.2 M | 15.2 M | 12 M | 13.4 M | 10 M | 3.9 M | (4.5 M) | 7.6 M | 1.1 M | 4.2 M | (27.3 M) | (1.5 M) | (11.5 M) | (10.4 M) | (9.9 M) |
| BJDX | (757.7 K) | (757.7 K) | (757.7 K) | (757.7 K) | (757.7 K) | (757.7 K) | (757.7 K) | (757.7 K) | (757.7 K) | (757.7 K) | (1.1 M) | (3.7 M) | (9.2 M) | (10 M) | (9 M) | (8.5 M) |
| IRIX | 1000 K | 2.6 M | 1.4 M | 2.2 M | 10 M | 474 K | (11.7 M) | (12.9 M) | (12.8 M) | (8.8 M) | (6.3 M) | (5.2 M) | (7.5 M) | (9.6 M) | (8.6 M) | (8.2 M) |
| AIMD | (300 K) | (1.3 M) | (650.8 K) | (622.6 K) | (622.6 K) | (521.9 K) | (670 K) | (617.4 K) | (1.3 M) | (1.6 M) | (1.5 M) | (3.9 M) | (14 M) | (13.8 M) | (14.9 M) | (14.1 M) |
| LNSR | (16.7 M) | (16.7 M) | (16.7 M) | (16.7 M) | (16.7 M) | (16.7 M) | (16.7 M) | (16.7 M) | (16.7 M) | (16.7 M) | (21.2 M) | (19.7 M) | (19.7 M) | (14.4 M) | (31.4 M) | (33 M) |
| LIVN | (5.1 M) | 36.1 M | 46.4 M | 54.9 M | 57.8 M | (29.6 M) | (62.8 M) | (25.1 M) | (189.4 M) | (155.5 M) | (343.3 M) | (135.7 M) | (86.2 M) | 17.5 M | 63.2 M | 66.4 M |
| KIDS | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (9.5 M) | (7.9 M) | (6.6 M) | (8.9 M) | (12 M) | (17.2 M) | (32.9 M) | (16.3 M) | 1.3 M | (21 M) | (37.8 M) | (35.9 M) |
| MODD | (30 K) | (17.5 K) | (20.8 K) | (22.8 K) | (31 K) | (31.1 K) | (106.6 K) | (106.6 K) | (2.5 M) | (5.3 M) | (7.4 M) | (18.6 M) | (13.9 M) | (17.5 M) | (15.7 M) | (14.9 M) |
| NPCE | (40.7 M) | (40.7 M) | (40.7 M) | (40.7 M) | (40.7 M) | (40.7 M) | (40.7 M) | (40.7 M) | (40.7 M) | (40.7 M) | (36 M) | (38.1 M) | (53.4 M) | (33 M) | (27.1 M) | (28.5 M) |
| SSKN | (2.3 M) | (20.4 M) | (22.7 M) | (25.9 M) | (16 M) | (27.9 M) | (3.3 M) | (21.5 M) | (4 M) | (4 M) | (4.4 M) | (2.7 M) | (5.5 M) | (10.8 M) | (9.7 M) | (10.2 M) |
Nexalin Technology and related stocks such as Ainos Inc, Electromed, and Armm Inc Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Nexalin Technology financial statement analysis. It represents the amount of money remaining after all of Nexalin Technology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Nexalin Technology Competitive Analysis
The better you understand Nexalin Technology competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Nexalin Technology's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Nexalin Technology's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Nexalin Technology Competition Performance Charts
Five steps to successful analysis of Nexalin Technology Competition
Nexalin Technology's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Nexalin Technology in relation to its competition. Nexalin Technology's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Nexalin Technology in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Nexalin Technology's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Nexalin Technology, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Nexalin Technology position
In addition to having Nexalin Technology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corona Opportunity Thematic Idea Now
Corona Opportunity
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Nexalin Technology Correlation with its peers. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.65) | Revenue Per Share | Quarterly Revenue Growth 0.494 | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.